2019
DOI: 10.1038/s41573-019-0041-4
|View full text |Cite
|
Sign up to set email alerts
|

Next-generation regulatory T cell therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
328
0
4

Year Published

2020
2020
2024
2024

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 366 publications
(351 citation statements)
references
References 247 publications
1
328
0
4
Order By: Relevance
“…Tregs have been used to induce tolerance in multiple autoimmune and inflammatory diseases 355‐358 . Consequently, adoptive transfer of Tregs has become an active area of research and clinical trial development for autoimmune diseases 359 . CD4 + CD25 + T cells can prevent the development of AA in C3H/HeJ mice, indicating some potential for Treg therapy 258 .…”
Section: Therapeutic Perspectivesmentioning
confidence: 99%
See 1 more Smart Citation
“…Tregs have been used to induce tolerance in multiple autoimmune and inflammatory diseases 355‐358 . Consequently, adoptive transfer of Tregs has become an active area of research and clinical trial development for autoimmune diseases 359 . CD4 + CD25 + T cells can prevent the development of AA in C3H/HeJ mice, indicating some potential for Treg therapy 258 .…”
Section: Therapeutic Perspectivesmentioning
confidence: 99%
“…CD4 + CD25 + T cells can prevent the development of AA in C3H/HeJ mice, indicating some potential for Treg therapy 258 . Once practical issues are addressed, 360 and the antigen epitopes targeted in AA are fully defined, 49,272,361 Treg cell therapy may be achievable for AA 359 . Similarly, NK cells with immunoregulatory properties, 277 and other immunoregulatory cell types, could be additional candidates for development into immunocell therapies.…”
Section: Therapeutic Perspectivesmentioning
confidence: 99%
“…Future investigations should evaluate whether antigen-specific tolerogenic strategies with the potential to exert a more potent effect on the disease can be used for treatment, particularly since these would avoid some of the more damaging side effects of global immune suppression. For instance, given the marked loss of antigen-specific Tregs we observed in Copa E241K/+ mice, regulatory T cell based therapy may be an exciting area for future research once the critical autoantigens targeted in disease are defined (27,42), especially in light of recent evidence which shows an important role for Tregs in constraining lung fibrosis (43).…”
Section: Future Investigations Should Evaluate Whether Disturbances Imentioning
confidence: 99%
“…Regulatory T cells (Tregs) control immune homeostasis and their adoptive transfer is a promising therapeutic approach with multiple trials completed, on-going or planned to test their efficiency in autoimmunity, solid organ transplantation or hematopoietic stem cell transplantation (reviewed in (Ferreira et al, 2019)). As Tregs are relatively rare, the majority of cell therapy protocols involve in vitro stimulation and expansion, in some cases culturing cells for up to 36 days to achieve > 2,000 fold expansion (MacDonald et al, 2019b).…”
Section: Introductionmentioning
confidence: 99%